Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin in Severe Persistent Asthma
NCT00689806Phase 2Withdrawn
- Sponsor
- University of Chicago
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lovastatin in severe asthma, sponsored by University of Chicago. Status: withdrawn.
02
Drugs
lovastatin
03
Conditions
severe asthma
Beyond the preview
Go deeper on NCT00689806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689806.